Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial - Udell, Jacob A.; Bhatt, Deepak L.; Braunwald, Eugene; Cavender, Matthew A.; Mosenzon, Ofri; Steg, Gabriel; Davidson, Jaime A.; Nicolau, Jose C.; Corbalan, Ramon; Hirshberg, Boaz; Frederich, Robert; Im, KyungAh; et al. (Diabetes Care, 2015)